Palo Alto Investors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-33,212	Closed	-$266K	–	41
2021 Q3	$266K	Hold	33,212	–	–	0.02%	40
2021 Q2	$377K	Hold	33,212	–	–	0.02%	39
2021 Q1	$307K	Sell	33,212 -1	-0%	-$9	0.02%	40
2020 Q4	$231K	Hold	33,213	–	–	0.01%	40
2020 Q3	$145K	Sell	33,213 -1	-0%	-$4	0.01%	42
2020 Q2	$306K	Hold	33,214	–	–	0.02%	39
2020 Q1	$482K	Hold	33,214	–	–	0.04%	32
2019 Q4	$393K	Hold	33,214	–	–	0.02%	32
2019 Q3	$837K	Hold	33,214	–	–	0.06%	31
2019 Q2	$845K	Hold	33,214	–	–	0.04%	32
2019 Q1	$1.41M	Hold	33,214	–	–	0.06%	31
2018 Q4	$483K	Hold	33,214	–	–	0.03%	32
2018 Q3	$2.33M	Hold	33,214	–	–	0.09%	29
2018 Q2	$2.46M	Hold	33,214	–	–	0.1%	29
2018 Q1	$3.16M	Hold	33,214	–	–	0.14%	28
2017 Q4	$4.29M	Hold	33,214	–	–	0.18%	29
2017 Q3	$2.26M	Hold	33,214	–	–	0.1%	30
2017 Q2	$3.14M	Hold	33,214	–	–	0.15%	27
2017 Q1	$4.77M	Hold	33,214	–	–	0.23%	26
2016 Q4	$4.21M	Hold	33,214	–	–	0.24%	26
2016 Q3	$5.08M	Hold	33,214	–	–	0.3%	29
2016 Q2	$3.82M	Hold	33,214	–	–	0.29%	31
2016 Q1	$3.77M	Hold	33,214	–	–	0.29%	31
2015 Q4	$6.26M	Hold	33,214	–	–	0.35%	28
2015 Q3	$5.65M	Buy	33,214 +28,898	+670%	+$4.92M	0.27%	32
2015 Q2	$2.73M	Buy	4,316 +1,443	+50%	+$912K	0.12%	36
2015 Q1	$1.48M	Buy	+2,873	New	+$1.48M	0.07%	40